Date | Company | Event | Description | Result |
---|---|---|---|---|
Lipocine | NDA FILING | LPCN 1021, low testosteron | Success | |
PTC Therapeutics | PHASE 3 | ATALUREN, Duchenne muscular dystrophy | Success | |
Genocea Biosciences | PHASE 2 | GEN-004, universal vaccine agains pneumococcus | Failure | |
Protalix BioTherapeutics | PHASE 1/2 | PRX-102, Fabry disease | Success |